Liu X - Search Results

1

Isocitrate dehydrogenase inhibitors in acute myeloid leukemia.

Liu X, Gong Y. Liu X, et al. Biomark Res. 2019 Oct 22;7:22. doi: 10.1186/s40364-019-0173-z. eCollection 2019. Biomark Res. 2019. PMID: 31660152 Free PMC article. Review.

2

The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysis.

Deng J, Wu X, Ling Y, Liu X, Zheng X, Ye W, Gong Y. Deng J, et al. Among authors: liu x. Eur J Haematol. 2020 Nov;105(5):524-539. doi: 10.1111/ejh.13483. Epub 2020 Jul 27. Eur J Haematol. 2020. PMID: 32621334

3

Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials.

Ye W, Wu X, Liu X, Zheng X, Deng J, Gong Y. Ye W, et al. Among authors: liu x. BMC Cancer. 2021 Sep 6;21(1):994. doi: 10.1186/s12885-021-08588-9. BMC Cancer. 2021. PMID: 34488679 Free PMC article.

4

The m⁶A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia.

Sang L, Wu X, Yan T, Naren D, Liu X, Zheng X, Zhang N, Wang H, Li Y, Gong Y. Sang L, et al. Among authors: liu x. J Cancer. 2022 Jan 4;13(3):1019-1030. doi: 10.7150/jca.60381. eCollection 2022. J Cancer. 2022. PMID: 35154467 Free PMC article.

5

Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.

Wu X, Deng J, Zhang N, Liu X, Zheng X, Yan T, Ye W, Gong Y. Wu X, et al. Among authors: liu x. BMC Cancer. 2022 Mar 12;22(1):262. doi: 10.1186/s12885-022-09347-0. BMC Cancer. 2022. PMID: 35279121 Free PMC article.

6

Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway.

Wang F, Huang J, Guo T, Zheng Y, Zhang L, Zhang D, Wang F, Naren D, Cui Y, Liu X, Qu Y, Luo H, Yang Y, Wei H, Guo Y. Wang F, et al. Among authors: liu x. Biochem Pharmacol. 2021 Jun;188:114538. doi: 10.1016/j.bcp.2021.114538. Epub 2021 Apr 6. Biochem Pharmacol. 2021. PMID: 33831397

7

Effect of 5-Aza-2'-deoxycytidine on T-cell acute lymphoblastic leukemia cell biological behaviors and PTEN expression.

Li Y, Jia Z, Kong X, Zhao H, Liu X, Cui G, Luo J. Li Y, et al. Among authors: liu x. Cytojournal. 2024 Oct 11;21:36. doi: 10.25259/Cytojournal_31_2024. eCollection 2024. Cytojournal. 2024. PMID: 39563669 Free PMC article.

8

Single-cell sequencing technology to characterize stem T-cell subpopulations in acute T-lymphoblastic leukemia and the role of stem T-cells in the disease process.

Li Y, Jia Z, Liu X, Zhao H, Cui G, Luo J, Kong X. Li Y, et al. Among authors: liu x. Aging (Albany NY). 2024 Oct 17;16(20):13117-13131. doi: 10.18632/aging.206123. Epub 2024 Oct 17. Aging (Albany NY). 2024. PMID: 39422621 Free PMC article.

9

[Relationship between Polymorphism of miR-155 and Its Target Gene MyD88 and Clinicopathological Features of Diffuse Large B-cell Lymphoma].

Li Y, Jia ZW, Kong XY, Cui GR, Liu XY. Li Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Jun;29(3):757-762. doi: 10.19746/j.cnki.issn.1009-2137.2021.03.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34105469 Chinese.

10

[The Expression and Correlation of miR-195, miR-125 and Calreticulin in Diffuse Large B-Cell Lymphoma].

Li Y, Liu XY, Cui GR, Kong XY, Yang L, Luo JM. Li Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):120-124. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.019. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 36765487 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,900 results

Search Page

Filters